Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score

BACKGROUND: Febrile neutropenia (FN) after chemotherapy causes a high burden of morbidity and mortality. We aimed to develop and validate a risk score to predict FN in the first cycle of chemotherapy. METHODS: We included patients with solid cancers and diffuse large B-cell lymphomas at Rigshospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Aagaard, Theis, Roen, Ashley, Reekie, Joanne, Daugaard, Gedske, Brown, Peter de Nully, Specht, Lena, Sengeløv, Henrik, Mocroft, Amanda, Lundgren, Jens, Helleberg, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649794/
https://www.ncbi.nlm.nih.gov/pubmed/31360873
http://dx.doi.org/10.1093/jncics/pky053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649794/
https://www.ncbi.nlm.nih.gov/pubmed/31360873
http://dx.doi.org/10.1093/jncics/pky053

Ejemplares similares